Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Diabetes
|
October 11, 2011
Duodenal PKC-δ and cholecystokinin signaling axis regulates glucose production
Danna M Breen, Jessica T Y Yue, Brittany A Rasmussen, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme
|
October 13, 2015
Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo
Sandra Pereira, Edward Park, Jessy Moore, et al.
Cell Metabolism
|
December 24, 2013
Jejunal leptin-PI3K signaling lowers glucose production
Brittany A Rasmussen, Danna M Breen, Frank A Duca, et al.
Metabolism: Clinical and Experimental
|
February 11, 2017
High-dose metformin (420mg/kg daily p.o.) increases insulin sensitivity but does not affect neointimal thickness in the rat carotid balloon injury model of restenosis
June Guo, Troy J Pereira, Prasad Dalvi, et al.
Expert Opinion on Drug Discovery
|
May 14, 2015
Latest approaches for the treatment of obesity
V Margaret Jackson, Danna M Breen, Jean-Philippe Fortin, et al.
Gastroenterology
|
January 17, 2012
Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats
Brittany A Rasmussen, Danna M Breen, Ping Luo, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
September 14, 2020
Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour model
Barbara Bernardo, Stephanie Joaquim, Jeonifer Garren, et al.
Nature Medicine
|
April 8, 2015
Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network
Clémence D Côté, Brittany A Rasmussen, Frank A Duca, et al.
Diabetes, Obesity & Metabolism
|
October 17, 2025
Evaluation of leptin treatment on maintenance of body weight loss in diet-induced obese mice
Danna M Breen, Rocío M Saavedra-Peña, Stephanie Joaquim, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
March 19, 2024
Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design
John D Groarke, Jeffrey Crawford, Susie M Collins, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Diabetes
|
October 11, 2011
Duodenal PKC-δ and cholecystokinin signaling axis regulates glucose production
Danna M Breen, Jessica T Y Yue, Brittany A Rasmussen, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme
|
October 13, 2015
Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo
Sandra Pereira, Edward Park, Jessy Moore, et al.
Cell Metabolism
|
December 24, 2013
Jejunal leptin-PI3K signaling lowers glucose production
Brittany A Rasmussen, Danna M Breen, Frank A Duca, et al.
Metabolism: Clinical and Experimental
|
February 11, 2017
High-dose metformin (420mg/kg daily p.o.) increases insulin sensitivity but does not affect neointimal thickness in the rat carotid balloon injury model of restenosis
June Guo, Troy J Pereira, Prasad Dalvi, et al.
Expert Opinion on Drug Discovery
|
May 14, 2015
Latest approaches for the treatment of obesity
V Margaret Jackson, Danna M Breen, Jean-Philippe Fortin, et al.
Gastroenterology
|
January 17, 2012
Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats
Brittany A Rasmussen, Danna M Breen, Ping Luo, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
September 14, 2020
Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour model
Barbara Bernardo, Stephanie Joaquim, Jeonifer Garren, et al.
Nature Medicine
|
April 8, 2015
Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network
Clémence D Côté, Brittany A Rasmussen, Frank A Duca, et al.
Diabetes, Obesity & Metabolism
|
October 17, 2025
Evaluation of leptin treatment on maintenance of body weight loss in diet-induced obese mice
Danna M Breen, Rocío M Saavedra-Peña, Stephanie Joaquim, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
March 19, 2024
Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design
John D Groarke, Jeffrey Crawford, Susie M Collins, et al.
Page
of 4